GAO Issues Report: Generic Drugs - Stakeholder Views on Improving FDA's Information on Patents
CR - GAO Reports
Copyright © Targeted News Service, 2023
Copyright © Targeted News Service, 2023
2023-03-18
Targeted News Service
WASHINGTON, March 18 -- The Government Accountability Office has issued a report (GAO-23-105477) entitled "Generic Drugs - Stakeholder Views on Improving FDA's Information on Patents."
Here are excerpts of summaries associated with the report.
What GAO Found: "The Food and Drug Administration (FDA) is required to publish information on patents for approved brand name drugs in a publication known as the Orange Book. FDA regulations describe to brand name drug companies ( . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, March 18 -- The Government Accountability Office has issued a report (GAO-23-105477) entitled "Generic Drugs - Stakeholder Views on Improving FDA's Information on Patents."
Here are excerpts of summaries associated with the report.
What GAO Found: "The Food and Drug Administration (FDA) is required to publish information on patents for approved brand name drugs in a publication known as the Orange Book. FDA regulations describe to brand name drug companies ( . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com